186 related articles for article (PubMed ID: 35390248)
1. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
Choi J; Park J; Cho I; Sheen Y
Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor.
Park J; Choi J; Cho I; Sheen YY
Sci Rep; 2022 Sep; 12(1):16104. PubMed ID: 36167880
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
[TBL] [Abstract][Full Text] [Related]
4. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
5. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.
Park CY; Son JY; Jin CH; Nam JS; Kim DK; Sheen YY
Eur J Cancer; 2011 Nov; 47(17):2642-53. PubMed ID: 21852112
[TBL] [Abstract][Full Text] [Related]
6. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
7. TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer.
Kim BN; Ahn DH; Kang N; Yeo CD; Kim YK; Lee KY; Kim TJ; Lee SH; Park MS; Yim HW; Park JY; Park CK; Kim SJ
Sci Rep; 2020 Jun; 10(1):10597. PubMed ID: 32606331
[TBL] [Abstract][Full Text] [Related]
8. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.
Boudreau HE; Casterline BW; Burke DJ; Leto TL
Br J Cancer; 2014 May; 110(10):2569-82. PubMed ID: 24714748
[TBL] [Abstract][Full Text] [Related]
9. Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer.
Ghauri MA; Su Q; Ullah A; Wang J; Sarwar A; Wu Q; Zhang D; Zhang Y
Phytomedicine; 2021 Apr; 84():153500. PubMed ID: 33626427
[TBL] [Abstract][Full Text] [Related]
10. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
12. TGF-β promote epithelial-mesenchymal transition via NF-κB/NOX4/ROS signal pathway in lung cancer cells.
Ma M; Shi F; Zhai R; Wang H; Li K; Xu C; Yao W; Zhou F
Mol Biol Rep; 2021 Mar; 48(3):2365-2375. PubMed ID: 33792826
[TBL] [Abstract][Full Text] [Related]
13. Enterolactone modulates the ERK/NF-κB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-β-induced epithelial-mesenchymal transition.
Mali AV; Joshi AA; Hegde MV; Kadam SS
Cancer Biol Med; 2018 May; 15(2):137-156. PubMed ID: 29951338
[TBL] [Abstract][Full Text] [Related]
14. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells.
Galarza TE; Táquez Delgado MA; Mohamad NA; Martín GA; Cricco GP
Biochem Pharmacol; 2020 Oct; 180():114177. PubMed ID: 32721509
[TBL] [Abstract][Full Text] [Related]
15. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis.
Son JY; Park SY; Kim SJ; Lee SJ; Park SA; Kim MJ; Kim SW; Kim DK; Nam JS; Sheen YY
Mol Cancer Ther; 2014 Jul; 13(7):1704-16. PubMed ID: 24817629
[TBL] [Abstract][Full Text] [Related]
16. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
[TBL] [Abstract][Full Text] [Related]
18. A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells.
Kantapan J; Paksee S; Duangya A; Sangthong P; Roytrakul S; Krobthong S; Suttana W; Dechsupa N
BMC Complement Med Ther; 2021 Jul; 21(1):189. PubMed ID: 34217266
[TBL] [Abstract][Full Text] [Related]
19. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
[TBL] [Abstract][Full Text] [Related]
20. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]